Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Journal of Clinical Medicine
|
February 7, 2020
Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
Gustavo M Viana, David A Priestman, Frances M Platt, et al.
Journal of Lipid Research
|
February 28, 2002
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Brett Garner, David A Priestman, Roland Stocker, et al.
The Journal of Biological Chemistry
|
August 10, 2014
A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology
Leigh Paton, Emmanuelle Bitoun, Janet Kenyon, et al.
Molecular Neurodegeneration
|
January 16, 2020
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease
Mylene Huebecker, Elizabeth B Moloney, Aarnoud C van der Spoel, et al.
Molecular Neurodegeneration
|
November 10, 2019
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease
Mylene Huebecker, Elizabeth B Moloney, Aarnoud C van der Spoel, et al.
Neurobiology of Aging
|
May 9, 2018
Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
Penelope J Hallett, Mylene Huebecker, Oeystein R Brekk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 25, 2022
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
Danielle Te Vruchte, Andrea Sturchio, David A Priestman, et al.
Glycoconjugate Journal
|
November 10, 2021
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease
Kerri-Lee Wallom, María E Fernández-Suárez, David A Priestman, et al.
Human Molecular Genetics
|
January 11, 2020
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
Giulia Massaro, Michael P Hughes, Sammie M Whaler, et al.
International Journal of Molecular Sciences
|
February 23, 2018
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
Aleksandra Somogyi, Anton Petcherski, Benedikt Beckert, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Journal of Clinical Medicine
|
February 7, 2020
Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
Gustavo M Viana, David A Priestman, Frances M Platt, et al.
Journal of Lipid Research
|
February 28, 2002
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Brett Garner, David A Priestman, Roland Stocker, et al.
The Journal of Biological Chemistry
|
August 10, 2014
A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology
Leigh Paton, Emmanuelle Bitoun, Janet Kenyon, et al.
Molecular Neurodegeneration
|
January 16, 2020
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease
Mylene Huebecker, Elizabeth B Moloney, Aarnoud C van der Spoel, et al.
Molecular Neurodegeneration
|
November 10, 2019
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease
Mylene Huebecker, Elizabeth B Moloney, Aarnoud C van der Spoel, et al.
Neurobiology of Aging
|
May 9, 2018
Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
Penelope J Hallett, Mylene Huebecker, Oeystein R Brekk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 25, 2022
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
Danielle Te Vruchte, Andrea Sturchio, David A Priestman, et al.
Glycoconjugate Journal
|
November 10, 2021
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease
Kerri-Lee Wallom, María E Fernández-Suárez, David A Priestman, et al.
Human Molecular Genetics
|
January 11, 2020
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
Giulia Massaro, Michael P Hughes, Sammie M Whaler, et al.
International Journal of Molecular Sciences
|
February 23, 2018
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
Aleksandra Somogyi, Anton Petcherski, Benedikt Beckert, et al.
Page
of 4